SeqOne Genomics: Funding, Investors & Team (Sep 2026)
SeqOne is a leading European provider of AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Its cloud-based platform transforms complex genomic data into fast, precise, and actionable insights, supporting molecular labs in delivering life-saving diagnoses and treatments. The SeqOne Platform is CE-IVD Class C certified under IVDR as an in vitro diagnostic medical device. Driven by the vision of personalized medicine for every patient, everywhere, SeqOne is scaling the future of genomic medicine—one lab at a time. The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
SeqOne Genomics has raised $45.3M across 2 funding rounds on record, the most recent an undisclosed round of $22.6M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SeqOne Genomics Company Profile and Key Stats
Latest funding round on record: May 2025.
SeqOne Genomics Funding Rounds
SeqOne Genomics raised $22.7M in a Series A announced in Jan 2022.
3.3 years later, an undisclosed round of $22.6M was announced in May 2025.
SeqOne Genomics Founders and Leadership Team
Contact details for the SeqOne Genomics team: 1 of 1 has an email address on file.
Start 14-day free trial →SeqOne Genomics Funding Compared to Other Biotechnology Startups
SeqOne Genomics' latest round of $22.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SeqOne Genomics in Biotechnology and Montpellier
Companies Similar to SeqOne Genomics
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
SeqOne Genomics Funding FAQs
What does SeqOne Genomics do?
SeqOne is a leading European provider of AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Its cloud-based platform transforms complex genomic data into fast, precise, and actionable insights, supporting molecular labs in delivering life-saving diagnoses and treatments. The SeqOne Platform is CE-IVD Class C certified under IVDR as an in vitro diagnostic medical device. Driven by the vision of personalized medicine for every patient, everywhere, SeqOne is scaling the future of genomic medicine—one lab at a time. The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. It has been nominated twice for the prestigious Prix Galien award. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club.
How much funding has SeqOne Genomics raised?
SeqOne Genomics has raised $45.3M across 2 rounds on record. The most recent is an undisclosed round of $22.6M announced in May 2025.
When did SeqOne Genomics last raise funding?
SeqOne Genomics' most recent funding round on record is an undisclosed round of $22.6M, announced in May 2025.
Who founded SeqOne Genomics?
FundedIQ lists Nicolas Philippe (Founder) at SeqOne Genomics.
Where is SeqOne Genomics headquartered?
SeqOne Genomics is based in Montpellier, Languedoc-Roussillon, France.
How many employees does SeqOne Genomics have?
SeqOne Genomics is in the 51-100 employee band.
How does SeqOne Genomics' funding compare to other Biotechnology startups?
SeqOne Genomics' latest round of $22.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SeqOne Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SeqOne Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.